IMS Health Holdings (IMS) has been under a strong bear grip, hence the stock is down -2.76% when compared to the S&P 500 in the past 4 weeks. However, in the near-term, buying emerged at lower levels and the stock has outperformed the S&P 500 by 1.22% in the past 1 week. The stock has risen by 0.55% in the past week indicating that the buyers are active at lower levels, but the stock is down -2.96% in the past 4 weeks.
For the current week, the company shares have a recommendation consensus of Buy. The stock has recorded a twenty day Moving Average of 1.39% and the fifty day Moving Average is 4.59%. IMS Health Holdings, Inc. is up 14.91% in the last three month period. Year-to-Date the stock performance stands at 14.37%.
IMS Health Holdings (IMS) : The highest level IMS Health Holdings (IMS) is projected to reach is $35 for the short term and the lowest estimate is at $28. The consolidated price target from 7 rating analysts who initiate coverage on the stock is $32.29 and the possibility the share price can swing is $2.21.
IMS Health Holdings (NYSE:IMS): On Fridays trading session , Opening price of the stock was $29.12 with an intraday high of $29.26. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $28.96. However, the stock managed to close at $29.13, a loss of 0.03% for the day. On the previous day, the stock had closed at $29.14. The total traded volume of the day was 210,195 shares.
IMS Health Holdings, Inc. (IMS) is an information and technology services company that provides solutions to its clients in the healthcare industry. The Company has its presence in over 100 countries. The Companys data set contains over 10 petabytes of data and over 500 million patient records. The Company serves healthcare organizations and life science companies, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community. The Companys principal offerings include national information offerings, sub-national information offerings, workflow analytics, real-world evidence (RWE) solutions, technology and applications and clinical solutions.